News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cynvenio Biosystems, Inc. Announces ClearID, a Breakthrough Test for Monitoring Breast Cancer Patients and Early Detection of Recurrence


10/3/2013 10:17:50 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LOS ANGELES--(BUSINESS WIRE)--Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of tumor biomarkers in blood, today launched a new weapon in the fight against breast cancer, the ClearID Breast Cancer monitoring program. ClearID Breast Cancer is a high-tech monitoring program that enables the early detection of breast cancer recurrence – a valuable tool that empowers patients to defend their health by actively monitoring for recurrence.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES